PARP Inhibitor Biomarkers Market is Anticipated to Witness High...

added blog Other

2024-02-27 12:27:15 -

PARP Inhibitor Biomarkers Market is Anticipated to Witness High Growth Owing to Increased Adoption of Precision Medicine

PARP inhibitor biomarkers are essential diagnostic tools for cancer treatment and identifying response rates to PARP inhibitor therapies. PARP inhibitors are increasingly used for the treatment of metastatic cancers with BRCA mutations. These inhibitors are primarily used for treating cancers like ovarian, breast, and prostate cancers. Rising cancer prevalence worldwide drives the adoption of...

0 Comments 0 Shares 1K Views 0 Reviews